Cancer
is the number one killer disease in Singapore today with one
out of four Singaporeans being affected by cancer during their
lifetime. Data from the Singapore Cancer Registry shows a
dramatic rise in the incidence of cancer in the last 30 years
- a yearly increase rate of 3.7 per cent.
Since
1993, the Run, previously named "Terry Fox" has
been organized by Four Seasons Hotel Singapore and The Regent
Singapore in conjunction with the Singapore Cancer Society.
A self-funding voluntary welfare organization, the Singapore
Cancer Society, views research as a vital aspect in its move
towards total Cancer control, treatment and care.
The
Run's Organizing Committee do not seek government funding
for administration or fundraising costs. Instead, they rely
on the generosity of the private sector and volunteers to
support research activities in the hope of finding a cure
for cancer.
Funds
raised each year are distributed as Research Grants in Singapore.
Every year, the Singapore Cancer Society receives numerous
requests of funding for Cancer research from doctors, researchers
and oncologists. After a stringent evaluation, its Executive
Committee awards these Research Grants.
In
2004, The Cancer Institute (TCI) and National Healthcare Group
(NHG) were awarded the "Cancer Research Grant 2004"
amounting to S$200,000 by the Singapore Cancer Society. The
grant, allocated through the Run's Fund went towards the following
cancer research project of Asso.Prof. CS Chen: "Preemptive
CD8+ T-cell depleted donor lymphocyte infusion following nonmyeloablative
stem cell transplantation: A novel cellular therapy for acute
myeloid leukemia or myelodysplastic syndrome"
In
2005, Research grants of S$100,000 raised from the Run were
each given to The Cancer Institute (TCI) and National Cancer
Centre (NCC):
*
Professor Yoshiaki Ito from The Cancer Institute (TCI): "The
Role of RUNX3 in colorectal carcinoma and in colorectal cancer
precursor leslons:relation in sporadic molecular pathways
and syndromic colorectal cancer".
*Professor
Chia Kee Seng from The Cancer Institute(TCI): "Discovering
ethnic differences in gene-environment interactions in major
cancers: Breast Cancer".
*Dr
Balram Chowbay from National Cancer Centre (NCC): "
Pharmacokinetic and pharmacogenetic profiling of rituximab
in combination with dose intense CHOP chemotherapy in Asian
patients with diffuse large B-cell lymphoma".
*Dr
Tan Min-Han from National Cancer Centre (NCC): "Global
chromosomal profiles of single-nucleotide polymorphisms of
kidney cancer tissue in association with global expression
and tyrosine kinome studies".
Your
contribution goes towards funding important research on cancer,
in the hope that one day the world will find a cure. All proceeds
from Run For Hope 2007 will go to grants awarded to clinical
researchers in Singapore for cutting-edge cancer research.
The grants will be awarded by the Singapore Cancer Society
after a rigorous review process.
In 2006, over $200,000 raised from the Run for Hope was awarded
to two researchers - Dr Yap Soon Sim and Dr Darran Lim of
the National Cancer Centre Singapore.
In 2007, $255,448 fund were granted to the following reseach institutions in Singapore:
Dr Aung Lele, Department of Paediatrics, National University Hospital Research project: Childhood cancer: The Hidden Medical and non-medical costs and it’s impact on the family Amount Awarded:$40,000.00
Dr Tang Bor Luen, Department of Biochemistry, National University of Singapore Research project : Investigations on the role of brain-enriched small GTPases in brain cancer Amount Awarded: $25,000.00
Dr Zhang Daohai, Department of Pathology, National University of Singapore Research Project : Oncogenic role and molecular mechanisms of ERP29 in breast cancer Amount Awarded:$98,600.00
Dr Wong Nan Soon, Department of Medical Oncology, National Cancer Centre Singapore Research Project : Randomised Phase II study of neoadjuvant weekly paclitaxel plus carboplatin (study arm) compared to weekly paclitaxel alone (standard arm) followed in both arms by standard doxorubicin and cyclophosphamide for operable or locally advanced basal-like subtype breast cancer Amount Awarded:$91,848.00
For
more information on Singapore's Cancer Society (SCS) visit
their website: www.singaporecancersociety.org.sg
Or
contact:
Angeline Eu
angeline_eu@singaporecancersociety.org.sg
DID:6221 9578
FAX:6221 9575
|
